The Belgian Charcot Foundation adheres to the guidelines of our health authorities: https://www.info-coronavirus.be/nl/ or https://www.info-coronavirus.be/fr/, which are updated when necessary.
The Belgian Charcot Foundation follows the advice of the Belgian Study Group for MS regarding the treatment of MS patients.
Today's heroes are not only the care workers, but also the men and women in the shadows in logistics, the post office, garbage collectors, etc., not forgetting the researchers. Their mission is to find ways to solve this crisis, today but also tomorrow.
MS patients are a high-risk group and, like the rest of the population, need to follow the recommendations scrupulously and more.
The Fondation Charcot Stichting remains available for any questions and will relay them to expert neurologists. Our fund-raising actions are continuing because tomorrow too, research will be essential to find better treatments, faster diagnosis and possible prevention.
With 500,000 euros, the Fondation Charcot Stichting provides the essential resources for 10 teams of experienced researchers in neurology, neuroimmunology, neurobiology and rehabilitation sciences to ensure innovative and concrete advances in multiple sclerosis research.
Multiple sclerosis is a chronic inflammatory disease of the central nervous system that affects over two million people worldwide. Patients may suffer from a wide range of disabling complaints which are not always easy to treat. Although cannabis is best known as a psychoactive recreational drug, it is also increasingly associated with a variety of positive medical effects.
Multiple sclerosis is the commonest neurological disease affecting young adults. In patients under 30, treatment needs to be adjusted accordingly.
